Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RETK666N Germline Pathogenic Variant

By sjmartinez • February 18, 2025

Yip AT, Kim TH, Peluso EM, Jacobsen SE, Yeh MW, Lechner MG. Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant. JCEM Case Rep. 2025 Feb 17;3(3):luaf002. doi: 10.1210/jcemcr/luaf002. PMID: 39963300; PMCID: PMC11831074.

Tags: Endocrinology, germline, medullary thyroid carcinoma, MEN2, pathogenic variant, Publications, RET K666N

Mdivi-1 regulates mitochondrial fission and function via the CaMK2/Drp1 pathway in amyotrophic lateral sclerosis

Shai Y, Alam M, Dong X, Zhang Y, Hu Y, He Z, Feng J, Chen Y, Zhou Z, Jiang H. Mdivi-1 regulates mitochondrial fission and[...]

Carbohydrate Counting in the Real World: Mealtime Insulin Dosing Behaviors and Smartphone App Use in Adults with Type 1 Diabetes

Everett EM, Shaw E, Escobar B, Cheng D, Tiu R, Lopez R, Menjivar Cruz J, Rivas Deras A, Polan D, Wisk LE, Moin T. Carbohydrate[...]

Exposure to per-and polyfluoroalkyl substances and early-onset cancers

van Gerwen M, Monaghan M, Boni A, Florentino Puello M, Petrick LM, Leung AM. Exposure to per-and polyfluoroalkyl substances and early-onset cancers. Carcinogenesis. 2026 Jul[...]